林清轩的上市动作早有苗头。 早在2 0 2 0年，林清轩创始人孙来春在接受媒体采访时就表示，公司在未来5年内要拥抱资本市 场，谋求上市。 今年2月，"上海林清轩生物科技有限公司"名称变更为"上海林清轩生物科技股份有限公司"， 同时公司董事长孙来春的职务调整为董事长兼总经理。股改完成，标志着林清轩迈出了上市第 一步。 随着上市步伐加快，这一家创立于2 0 0 3年的中国美妆公司将开启新篇章。 林清轩敢于迈向资本市场，其底气既得益于品牌当下已然成熟且稳固的市场格局，更源于其在 渠道拓展与产品布局两端构建起的综合战略体系。 5月2 9日，上海林清轩生物科技股份有限公司（以下简称"林清轩"）正式向港交所递交招股说 明 书 ， 拟 主 板 挂 牌 上 市 ， 中 信 证 券 和 华 泰 国 际 担 任 联 席 保 荐 人 。 若 顺 利 ， 林 清 轩 将 成 为 港 股"中国高端护肤第一股"。 从林清轩披露的招股书数据来看，2 0 2 2年至2 0 2 4年期间，公司营收呈现出稳健且快速的增长 态 势 ， 分 别 为 6 . 9 1 亿 元 、 8 . 0 5 亿 元 、 1 2 . 1 亿 元 ， 复 合 年 增 ...

Group 1 - The 2025 Shanghai Cooperation Organization (SCO) Media Cooperation Forum was held in Urumqi, Xinjiang, with over 300 representatives from 26 countries discussing cooperation under the theme "Building a Better Home Together for a Prosperous Future" [1] - Since its establishment in 2001, the SCO has adhered to the "Shanghai Spirit" of mutual trust, mutual benefit, equality, consultation, respect for diverse civilizations, and seeking common development [1] - China will assume the rotating presidency of the SCO for 2024-2025, with expectations for China to lead new cooperation initiatives and strengthen the collective power of developing countries in global governance [1] Group 2 - The domestic skincare brand Gu Yu showcased its product "Four Seasons Boundless," which combines Chinese efficacy skincare technology with poetic aesthetics, attracting attention from international guests [3] - Gu Yu focuses on Chinese skin types and ingredients, exploring a path of scientific skincare centered on Chinese characteristics, reflecting the cultural depth and research strength of Chinese cosmetic brands [3][4] - The "Four Seasons Boundless" includes two products, "Boundless Electric Cream" and "Four Seasons Spiritual Dew," showcasing Gu Yu's research and innovation capabilities [4] Group 3 - "Boundless Electric Cream" utilizes three core technologies, including self-developed composite enzyme biomimetic transformation technology, plant stem cell culture technology, and synthetic biology technology, featuring key active ingredients like rare ginseng saponin CK and snow lotus stem cells [4] - "Four Seasons Spiritual Dew" is formulated with seasonal herbs such as ginseng and peony, aiming to provide revitalizing energy for consumers seeking a healthy complexion [4] - Gu Yu has established a library of "Chinese core" active ingredients, including aurora licorice and rare ginseng saponin CK, to meet diverse skincare needs across different consumer segments [4] Group 4 - Gu Yu has maintained its commitment to promoting Chinese culture through skincare products, with the "Four Seasons Boundless" adopting a unique design inspired by traditional Chinese aesthetics, winning multiple international design awards [6] - The brand aims to showcase its determination to empower "Chinese core" ingredients and efficacy to the world, while expressing cultural confidence and charm through its products [8]

Core Viewpoint - Lin Qingxuan is the only domestic high-end skincare brand among the top 15 in China, focusing on anti-wrinkle and firming products, with a strong emphasis on natural ingredients like camellia oil [1][7]. Company Overview - Founded in 2003, Lin Qingxuan specializes in high-end skincare products, particularly those based on camellia flower ingredients [3]. - The flagship product, Camellia Essence Oil, launched in 2014, has sold over 30 million bottles and has been the top-selling facial essence oil in China for 11 consecutive years [5]. Product Development - Lin Qingxuan has developed a range of patented ingredients and products, including various serums, creams, and masks, totaling 188 SKUs as of December 31, 2024 [6]. - The company has introduced several successful products, such as the Camellia Black Gold Anti-Wrinkle Cream, generating significant revenue in its first year [6]. Market Position - As of 2024, Lin Qingxuan ranks first among domestic high-end skincare brands in China and is the only domestic brand in the top 15 overall [7]. - The brand leads the market in high-end anti-wrinkle and firming products among domestic brands [7]. Customer Engagement - Lin Qingxuan has over 4.3 million active customers, with an average annual repurchase rate of approximately 34.6%, surpassing the industry average [8]. Distribution Channels - The company operates 506 stores, primarily in shopping malls, with a significant portion being direct-operated stores, ensuring consistent customer experience [10]. - Online sales have seen rapid growth, with a compound annual growth rate of 51.2% from 2022 to 2024 [10]. Financial Performance - Lin Qingxuan's revenue has grown from 691 million yuan in 2022 to 1.21 billion yuan in 2024, with a compound annual growth rate of 32.5% [12]. - The company achieved profitability in 2023, with adjusted net profits exceeding 200 million yuan in 2024 [13]. Future Plans - Lin Qingxuan aims to expand into Southeast Asian markets as part of its globalization strategy [11]. - The company plans to use IPO proceeds to enhance brand value, sales networks, production capabilities, and technological development [14]. Industry Outlook - The high-end skincare market in China is projected to grow from 74.9 billion yuan in 2019 to 114.4 billion yuan in 2024, with anti-wrinkle products expected to see a compound annual growth rate of 21.2% [14].

Core Viewpoint - Lin Qingxuan is poised to become the first high-end domestic skincare stock in Hong Kong, having submitted its prospectus to the Hong Kong Stock Exchange, highlighting its leadership in the high-end domestic skincare market in China [1] Industry Overview - The Chinese cosmetics market is expanding, driven by increased consumer focus on health and appearance, digital transformation in shopping behavior, and innovation in cosmetics [1] - The skincare segment holds the largest market share, with the market size growing from RMB 332.9 billion in 2019 to RMB 461.9 billion in 2024, reflecting a compound annual growth rate (CAGR) of 6.8% [1] Company Performance - Lin Qingxuan's total revenue is projected to grow from RMB 691 million in 2022 to RMB 1.21 billion in 2024, achieving a CAGR of 32.3% [2] - The company's net profit is expected to reach RMB 187 million in 2024 [2] Market Trends - The market for high-end anti-wrinkle and firming skincare products is anticipated to increase from RMB 59.4 billion in 2024 to RMB 155.5 billion by 2029, with a CAGR of 21.2% [2] - The overall high-end skincare market in China is expected to reach RMB 218.5 billion by 2029, with a CAGR of 13.8% from 2024 to 2029 [2] Strategic Outlook - As a leading brand in the high-end domestic skincare sector, Lin Qingxuan is expected to benefit from its strong R&D capabilities and existing product leadership [2] - The company aims to align its product strategy with evolving consumer demands, focusing on core products and expanding its product matrix to offer customized skincare solutions [2]

Summary of the Conference Call for Juzi Biotechnology Company Overview - **Company**: Juzi Biotechnology - **Key Brands**: Kefu Mei and Keli Jin Industry Insights - **Market Trends**: The recombinant collagen market continues to show strong growth potential, with no signs of slowing down. The demand for products in this category remains robust, as evidenced by the high growth rates of key products and positive feedback from new product launches [4][10]. Core Points and Arguments - **Product Innovation**: Juzi Biotechnology is driving growth through product iterations, such as the upgrade of collagen peptide to version 2.0, and the introduction of new products like Focus Cream and Honey Repair Cream. These new products have received positive feedback from distribution channels and are expected to become new growth drivers [2][5]. - **Kefu Mei Brand Strengths**: Kefu Mei focuses on efficacy and safety, having established professional trust through medical device certification. The brand is expanding its product line into niche areas such as acne treatment and thermal injury repair, while also enhancing offline direct store presence to improve market performance [2][9]. - **Sales Performance**: Kefu Mei's collagen stick accounts for approximately 30% of total sales and continues to grow rapidly. The new customer acquisition rate is close to 50%, with a repurchase rate significantly higher than the industry average [2][12]. - **Keli Jin Brand Dynamics**: Keli Jin has achieved short-term growth through organizational restructuring and product line optimization. However, long-term growth may face challenges due to potential limitations in collagen technology for anti-aging effects [2][20]. - **Regulatory Challenges**: Sales of Class II medical device products are growing steadily, but the approval process for Class III medical devices is slow, with uncertain timelines for specific approvals despite receiving priority review qualifications for collagen fillers [2][21]. Financial Performance - **Revenue Growth**: Juzi Biotechnology has experienced rapid revenue and profit growth, although the sales expense ratio has increased. The company plans to control this ratio through product combination sales and customer referral strategies [6][7]. Marketing and Competitive Landscape - **Competitive Positioning**: Kefu Mei differentiates itself from competitors by emphasizing safety and efficacy. The brand has established a strong medical aesthetic image through partnerships with hospitals and medical institutions, contrasting with competitors that rely on celebrity endorsements [17][25]. - **Market Competition**: While other brands have launched collagen products, Kefu Mei's unique positioning and established trust in safety and efficacy mitigate significant competitive threats. The market is expanding collectively rather than through direct competition [25]. Product Strategy - **Product Development**: Kefu Mei's strategy includes launching successful single products and then expanding related skincare offerings. The brand also targets various consumer needs with different product forms [11][12]. - **New Product Launches**: The Focus Cream and Zhenyu Secret Repair Cream have distinct market positions, with the latter targeting a high-end consumer segment and addressing specific skin repair needs [18]. Future Outlook - **Growth Projections**: Kefu Mei is expected to achieve a growth rate of 40% to 50% in Q1 2025, with an annual performance forecast of 25% to 28%. The overall performance is anticipated to remain stable due to new product launches and marketing strategies [10][19]. Additional Considerations - **Consumer Sentiment**: Recent controversies regarding product ingredient content are not expected to significantly impact the company's fundamentals, as consumer recognition of product efficacy remains high [3][24]. - **Offline Expansion**: Kefu Mei has begun establishing offline direct stores, with plans to open 40 new locations in 2025. This strategy aims to enhance member interaction and improve market performance [22][23].

Core Viewpoint - The domestic medical beauty industry is facing significant scrutiny due to allegations regarding the quality and labeling of collagen products, particularly targeting the leading company, Giant Bio, and its flagship product, "Collagen Stick" [1][5][6]. Industry Overview - The controversy highlights the lack of national standards for the testing of recombinant collagen in cosmetics, leading to significant discrepancies in test results as companies rely on self-defined methods or pharmaceutical industry standards [5][6]. - The National Medical Products Administration has initiated the establishment of industry standards for recombinant collagen and its testing methods, with companies participating in the process [5]. Company-Specific Issues - Giant Bio's "Collagen Stick" was accused of having a collagen content of only 0.0177%, which is below the national cosmetic labeling requirement of 0.1% for non-trace additives, and the key amino acid glycine was reportedly not detected [6][8]. - In response to the allegations, Giant Bio issued a statement denying the claims, asserting that their products meet the required standards and have been approved by regulatory authorities [8]. Testing Method Discrepancies - The testing methods used by the parties involved differ significantly; the blogger employed a high-precision HPLC method, while Giant Bio referenced outdated national standards that have been criticized for their ineffectiveness in the current complex cosmetic landscape [9][10]. - The HPLC method is noted for its high sensitivity and ability to accurately quantify amino acids, while the methods referenced by Giant Bio have been deemed inadequate for testing collagen in cosmetics [10][15]. Market Impact - Following the allegations, Giant Bio's stock price fell over 8% on the Hong Kong Stock Exchange, closing down 4.04%, reflecting market concerns over the credibility of its products [8].

Core Insights - PMPM successfully leveraged social media marketing strategies during the 618 shopping festival, focusing on the Gen Z demographic, particularly those born in the 1990s and 2000s, by creating a content matrix across platforms like Xiaohongshu, Douyin, and Bilibili [1][2][9] Group 1: Marketing Strategy - The brand's core philosophy is "exploring the world and bringing distant experiences to consumers," targeting young consumers who seek emotional resonance and refined living [5][6] - The marketing campaign was structured in phases: pre-event buildup in April, peak interaction in May with key influencers, and intensified promotions in June, followed by a long-tail engagement strategy in July [12][13][14] - The influencer strategy involved a mix of "long-tail influencers for broad penetration, head influencers for heat generation, and mid-tier influencers for community impact," with over 60% of beauty influencers participating [1][2][17] Group 2: Content and Engagement - Content strategies focused on product ingredients and consumer pain points, with practical guides and lists released during the 618 event, such as "summer acid brushing" and "must-buy items" [2][24] - PMPM achieved over 100 million in sales during the 618 period, with the seaweed essence lotion set topping the category charts and Douyin's GMV increasing by 466% [2][7] - The success was attributed to precise audience matching on platforms, a layered influencer strategy, and emotionally resonant content that combined travel and skincare themes [2][8][9] Group 3: Brand Development - PMPM was founded in October 2019, focusing on storytelling through emotions and unique global formulations, quickly gaining traction in the market [6][7] - The brand's growth trajectory included angel funding in early 2020 and subsequent rounds, achieving a GMV of 150 million within six months of launch and surpassing 300 million by 2020 [6][7] - PMPM's commitment to sustainability was highlighted by its participation in the UN Biodiversity Conference, showcasing its responsibility as a brand [6][7] Group 4: Target Audience - PMPM's target demographic includes young consumers aged 18-35, who prioritize emotional experiences and refined lifestyles, with a strong presence on social media platforms [9][10] - The brand's marketing efforts are tailored to resonate with the values and interests of Gen Z, focusing on self-expression and emotional connection [9][10]

Company Overview - Kefu Mei is a well-known brand under Shaanxi Juzhi Biological Technology Co., Ltd, focusing on medical dressings, functional skincare products, and biomaterials, particularly in the field of human-like collagen, holding a leading position in the industry [5] - Juzhi Biological primarily offers recombinant collagen products and operates in the medical aesthetics segment, with brands including "Kefu Mei," "Keli Jin," and "Xin Gan," and successfully went public on the Hong Kong Stock Exchange in 2022 [5] Financial Performance - From 2020 to 2024, Juzhi Biological's revenue figures are projected to be 1.19 billion, 1.55 billion, 2.36 billion, 3.52 billion, and 5.54 billion yuan respectively, showing a consistent year-on-year growth trend [5] - The net profit attributable to the parent company for the same period is expected to be 826 million, 828 million, 1.00 billion, 1.45 billion, and 2.06 billion yuan, also reflecting steady growth [5] - In 2024, Kefu Mei's GMV growth rate is expected to exceed 80%, contributing 4.54 billion yuan in revenue, which accounts for 82% of the total revenue [5] Market Trends - Recombinant collagen, synthesized through genetic engineering, is increasingly replacing hyaluronic acid and animal-derived collagen, becoming a new trend in the medical aesthetics sector [6] - The Chinese recombinant collagen market is projected to grow at a compound annual growth rate of 44.93%, reaching a market size of 219.38 billion yuan by 2030 [6][7] Product Integrity and Compliance - Kefu Mei has firmly denied allegations of product integrity issues, stating that all product development and production strictly adhere to cosmetic regulations and that all ingredient labeling complies with legal standards [1] - The company conducted multiple tests on its products, confirming that collagen content exceeds 0.1%, contradicting claims of a 0.0177% addition [1][3]

（文章来源：中国新闻网） 中新网宁波5月23日电(奚金燕)塞尔维亚草甸蜂蜜、匈牙利贵腐酒、保加利亚玫瑰制品……22日，第四 届中国—中东欧国家博览会暨国际消费品博览会(以下简称"中东欧博览会")在浙江宁波举办。现场汇聚 了8000多种中东欧特色商品，吸引了许多中国采购商"下单"。 走进"数智中东欧"展区，来自斯洛伐克的马丁·扎加克此次虽然没有带来实体产品，但还是吸引了不少 中国采购商的目光。他此次主要分享企业自主研发的航空气象监测系统，主要通过在机场附近建设专业 气象站以实现复杂天气的预警，目前已经在云南、海口落地。 "中国非常重视发展低空经济，我相信接下来还有很多合作机遇。"马丁·扎加克认为，中国正在低空经 济领域构建起一套涵盖研发制造、运营服务、基础设施等全链条的产业生态经济。他希望能够借助中东 欧博览会进一步抢占市场先机。 据悉，本届中东欧博览会吸引来自中东欧14国和英国、法国、德国、西班牙、意大利等9个国家的435家 企业参展。展区既有水晶、啤酒、葡萄酒、蜂蜜、奶酪等传统中东欧好物，又有VR眼镜、智能家电等 代表高科技产品，为中国采购商、消费者带来了多元化的选择。 展会首日就有24个采购项目达成签约， ...

贝泰妮向记者透露，集团正构建起"科技-生态-社区"三维保护网络持续进行一系列的实践，旨在将技术 创新、生态修复与社区发展深度耦合，形成生物多样性保护的闭环体系，包括哈巴雪山保护区实施多维 度保护计划，建成科普宣教中心和植物保育大棚，实现20余种高山珍稀植物扩繁，并启动西坡原生植被 修复工程；针对滇金丝猴栖息地破碎化问题，在老君山布设红外及鸟类监测设备，构建覆盖320平方公 里的科学监测网络，首次完整记录滇金丝猴幼崽群体活动影像。 值得一提的是，云南《生物多样性保护战略（2024-2030）》将企业参与列为优先事项，与证监会《可 持续发展报告指引》形成政策协同。作为云南上市企业，贝泰妮表示，未来也将以可持续发展理念为行 动指引，探索着"战略与行动规划"所指出的"保护与可持续利用生物多样性长效机制"，为消费者带来更 优质产品体验的同时，也致力于守护这片土地的生态平衡。 （文章来源：广州日报） 5月22日是国际生物多样性日。今年国际生物多样性日的主题是"万物共生和美永续"，呼吁以人与自然 和谐共生之道，创和美永续之路，凝聚起保护生物多样性的共识。其中，云南以我国生物多样性最丰富 的生态优势，为全球生物多样性治理提供 ...